26118667|t|Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
26118667|a|Chronic brain hypoperfusion (CBH) is a common clinical feature of Alzheimer's disease and vascular dementia, but the underlying molecular mechanism is unclear. Our previous study reported that the down-regulation of microRNA-195 (miR-195) promotes amyloidogenesis via regulation of amyloid precursor protein and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) expression at the post-transcriptional level in CBH rats with bilateral common carotid artery occlusion (2VO). CBH owing to unilateral common carotid artery occlusion (UCCAO) increases tau phosphorylation levels at multiple phosphorylation sites in the brain, but the molecular mechanism is poorly understood. The purpose of this study was to investigate whether miR-195 could both deregulate amyloid metabolism and indirectly deregulate tau phosphorylation in CBH. We observed that 2VO leads to tau hyperphosphorylation at Ser202/Thr205, Ser262, Thr231, and Ser422 and to the conversion from cyclin-dependent kinase 5 (Cdk5)/p35 to Cdk5/p25 in rat hippocampi. Endogenous miR-195 was knocked down using over-expression of its antisense molecule (pre-AMO-miR-195) via a lentivirus (lenti-pre-AMO-miR-195); this knockdown increased the tau phosphorylation at Ser202/Thr205, Ser262, Thr231, Ser422, and the Cdk5/p25 activation, but over-expression of miR-195 using lenti-pre-miR-195 decreased the tau phosphorylation and Cdk5/p25 activation. Further in vitro studies demonstrated that miR-195 over-expression prevented tau hyperphosphorylation and Cdk5/p35 activity, which were increased by miR-195 inhibition. A dual luciferase reporter assay showed that miR-195 bound to the Cdk5r1 gene, which encodes p35 protein, in the 3'UTR and inhibited p35 expression. We concluded that tau hyperphosphorylation involves the down-regulation of miR-195, which is mediated by Cdk5/p25 activation in 2VO rats. Our findings demonstrated that down-regulation of miR-195 led to increased vulnerability via the regulation of multiple targets. Schematic diagram of miR-195 mediated Abeta aggregation and tau hyperphosphorylation in chronic brain hypoperfusion (CBH). First, CBH results in the elevation of nuclear factor-kappaB (NF-kappaB), which binds with the promoter sequences of miR-195 and negatively regulates the expression of miR-195. Second, down-regulated miR-195 induces up-regulation of APP and BACE1 and leads to an increase in Abeta levels. Third, some of the elevated Abeta then enter the intracellular space and activate calpain, which promotes the conversion of Cdk5/p35 to Cdk5/p25 and catalyzes the degradation of IkappaB; IkappaB is an inhibitor of NF-kappaB, which activates NF-kappaB. Cdk5/p25 directly phosphorylates Tau. Fourth, down-regulated miR-195 induces an up-regulation of p35, which provides the active substrates of p25. Our findings demonstrated that the down-regulation of miR-195 plays a key role in the increased vulnerability to dementia via the regulation of multiple targets following CBH. 
26118667	14	18	Cdk5	Gene	140908
26118667	19	22	p25	Gene	170496
26118667	57	84	chronic brain hypoperfusion	Disease	MESH:D020208
26118667	88	92	rats	Species	10116
26118667	102	114	microRNA-195	Gene	100314281
26118667	132	159	Chronic brain hypoperfusion	Disease	MESH:D020208
26118667	161	164	CBH	Disease	MESH:D020208
26118667	198	217	Alzheimer's disease	Disease	MESH:D000544
26118667	222	239	vascular dementia	Disease	MESH:D015140
26118667	348	360	microRNA-195	Gene	100314281
26118667	362	369	miR-195	Gene	100314281
26118667	380	395	amyloidogenesis	Disease	
26118667	414	439	amyloid precursor protein	Gene	54226
26118667	444	497	beta-site amyloid precursor protein cleaving enzyme 1	Gene	29392
26118667	499	504	BACE1	Gene	29392
26118667	554	557	CBH	Disease	MESH:D020208
26118667	558	562	rats	Species	10116
26118667	578	609	common carotid artery occlusion	Disease	MESH:D002340
26118667	611	614	2VO	Disease	
26118667	617	620	CBH	Disease	MESH:D020208
26118667	641	672	common carotid artery occlusion	Disease	MESH:D002340
26118667	674	679	UCCAO	Disease	MESH:D002340
26118667	869	876	miR-195	Gene	100314281
26118667	899	906	amyloid	Disease	MESH:C000718787
26118667	967	970	CBH	Disease	MESH:D020208
26118667	989	992	2VO	Chemical	-
26118667	1099	1124	cyclin-dependent kinase 5	Gene	140908
26118667	1126	1130	Cdk5	Gene	140908
26118667	1132	1135	p35	Gene	116671
26118667	1139	1143	Cdk5	Gene	140908
26118667	1144	1147	p25	Gene	170496
26118667	1151	1154	rat	Species	10116
26118667	1178	1185	miR-195	Gene	100314281
26118667	1260	1267	miR-195	Gene	100314281
26118667	1301	1308	miR-195	Gene	100314281
26118667	1410	1414	Cdk5	Gene	140908
26118667	1415	1418	p25	Gene	170496
26118667	1454	1461	miR-195	Gene	100314281
26118667	1478	1485	miR-195	Gene	100314281
26118667	1524	1528	Cdk5	Gene	140908
26118667	1529	1532	p25	Gene	170496
26118667	1588	1595	miR-195	Gene	100314281
26118667	1651	1655	Cdk5	Gene	140908
26118667	1656	1659	p35	Gene	116671
26118667	1694	1701	miR-195	Gene	100314281
26118667	1759	1766	miR-195	Gene	100314281
26118667	1780	1786	Cdk5r1	Gene	116671
26118667	1807	1810	p35	Gene	116671
26118667	1847	1850	p35	Gene	116671
26118667	1881	1905	tau hyperphosphorylation	Disease	MESH:C536599
26118667	1938	1945	miR-195	Gene	100314281
26118667	1968	1972	Cdk5	Gene	140908
26118667	1973	1976	p25	Gene	170496
26118667	1991	1994	2VO	Disease	
26118667	1995	1999	rats	Species	10116
26118667	2051	2058	miR-195	Gene	100314281
26118667	2151	2158	miR-195	Gene	100314281
26118667	2168	2173	Abeta	Gene	54226
26118667	2218	2245	chronic brain hypoperfusion	Disease	MESH:D020208
26118667	2247	2250	CBH	Disease	MESH:D020208
26118667	2260	2263	CBH	Disease	MESH:D020208
26118667	2370	2377	miR-195	Gene	100314281
26118667	2421	2428	miR-195	Gene	100314281
26118667	2453	2460	miR-195	Gene	100314281
26118667	2494	2499	BACE1	Gene	29392
26118667	2528	2533	Abeta	Gene	54226
26118667	2570	2575	Abeta	Gene	54226
26118667	2666	2670	Cdk5	Gene	140908
26118667	2671	2674	p35	Gene	116671
26118667	2678	2682	Cdk5	Gene	140908
26118667	2683	2686	p25	Gene	170496
26118667	2794	2798	Cdk5	Gene	140908
26118667	2799	2802	p25	Gene	170496
26118667	2855	2862	miR-195	Gene	100314281
26118667	2891	2894	p35	Gene	116671
26118667	2936	2939	p25	Gene	170496
26118667	2995	3002	miR-195	Gene	100314281
26118667	3054	3062	dementia	Disease	MESH:D003704
26118667	3112	3115	CBH	Disease	MESH:D020208
26118667	Negative_Correlation	100314281	140908
26118667	Association	MESH:C536599	170496
26118667	Association	100314281	54226
26118667	Association	100314281	116671
26118667	Association	MESH:D020208	170496
26118667	Negative_Correlation	MESH:D002340	100314281
26118667	Association	MESH:D020208	29392
26118667	Association	MESH:D003704	100314281
26118667	Association	100314281	29392
26118667	Association	MESH:D020208	100314281
26118667	Association	100314281	170496
26118667	Association	MESH:D020208	140908
26118667	Association	MESH:D020208	54226
26118667	Association	MESH:C536599	100314281

